Peer-reviewed publications

Selected publications on DR-TB 2012-2013 from HMS/BWH/Partners In Health group

  1. Lu C, Liu Q, Sarma A, Fitzpatrick C, Falzon D, Mitnick CD. A systematic review of reported cost for smear and culture tests during multidrug-resistant tuberculosis treatment. PloS one 2013;8:e56074. (Full text)

  2. Becerra MC, Franke MF, Appleton SC, Joseph JK, Bayona J, Atwood SS, Mitnick CD. Tuberculosis in children exposed at home to multidrug-resistant tuberculosis. Pediatric Infectious Disease Journal 2013;32(2):115-9. (Full text)

  3. Dharmadhikari AS, Kabadi M, Gerety B, Hickey AJ, Fourie PB, Nardell E. Phase I, single-dose, dose-escalating study of inhaled dry powder capreomycin: a new approach to therapy of drug-resistant tuberculosis. Antimicrobial Agents and Chemotherapy 2013;57:2613-9. (Abstract)

  4. Dooley KE, Obuku EA, Durakovic N, Belitsky V, Mitnick C, Nuermberger EL on behalf of the Efficacy Sub-group, RESIST-TB. World Health Organization Group 5 Drugs for the treatment of drug-resistant tuberculosis: Unclear efficacy or untapped potential? J Infect Dis 2013; 207(9):1352-8. (Full text)

  5. Franke MF, Appleton SC, Mitnick CD, et al. Aggressive regimens for multidrug-resistant tuberculosis reduce recurrence. Clinical Infectious Diseases 2013;56:770-6. (Full text)

  6. Horsburgh CR Jr, Haxaire-Theeuwes M, Lienhardt C, Wingfield C, McNeeley D, Pyne-Mercier L, Keshavjee S, Varaine F; Research Excellence to Stop TB Resistance (RESIST-TB); Critical Path to TB Drug Regimens' Access and Appropriate Use Workgroup. Compassionate use of and expanded access to new drugs for drug-resistant tuberculosis. Int J Tuberc Lung Dis. 2013 Feb;17(2):146-52. (Full text)

  7. Hwang TJ, Wares DF, Jafarov A, Jakubowiak W, Nunn P, Keshavjee S. Safety of cycloserine and terizidone for the treatment of drug-resistant tuberculosis: a meta-analysis [Review article]. Int J Tuberc Lung Dis. 2013 Oct;17(10):1257-66. doi: 10.5588/ijtld.12.0863. Epub 2013 Jun 3. (Abstract)

  8. Mitnick CD, Franke MF, Rich ML, et al. Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality. PLOS ONE 2013;8:e58664. (Full text)

  9. Mitnick CD, Keravec J, Cohen T. Planning for the invisible: projecting resources needed to identify and treat all patients with MDR-TB. International Journal of Tuberculosis and Lung Disease 2013;17:427-8. (Full text)

  10. Satti H, McLaughlin MM, Seung KJ. Drug-resistant tuberculosis treatment complicated by antiretroviral resistance in HIV coinfected patients: a report of six cases in Lesotho. Am J Trop Med Hyg. 2013 Jul;89(1):174-7. doi: 10.4269/ajtmh.13-0046. Epub 2013 May 13. (Abstract)

  11. Seung KJ, Becerra MC, Atwood SS, Alcántara F, Bonilla CA, Mitnick CD. Salvage therapy for multidrug-resistant tuberculosis. Clin Microbiol Infect. 2013 Jul 18. doi: 10.1111/1469-0691.12335. [Epub ahead of print] (Abstract)

  12. Seung KJ, Linton SW. The growing problem of multidrug-resistant tuberculosis in North Korea. PLOS Med. 2013 Jul;10(7):e1001486. doi: 10.1371/journal.pmed.1001486. Epub 2013 Jul 30. (Full text)

  13. Yuen CM, Tolman AW, Cohen T, Parr JB, Keshavjee S, Becerra MC. Isoniazid-resistant tuberculosis in children: a systematic review. Pediatr Infect Dis J. 2013 May;32(5):e217-26. doi: 10.1097/INF.0b013e3182865409. (Abstract)

  14. Cohen T, Manjourides J, Hedt-Gauthier B. Linking surveillance with action against drug-resistant tuberculosis. American Journal of Respiratory and Critical Care Medicine 2012;186:399-401. (Full text)

  15. Dooley KE, Mitnick CD, DeGroote AM, Obuku E, Belitsky V, Hamilton CD, Makhene M, Shah S, Brust JC, Durakovic N, Nuermberger E; on behalf of the Efficacy Sub-group, RESIST-TB. Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosis. Clinical Infectious Diseases 2012;55:572-81. (Full text)

  16. Miller AC, Gelmanova IY, Keshavjee S, Atwood S, Yanova G, Mishustin S, Furin JJ, Shin SS. Alcohol use and the management of multidrug-resistant tuberculosis in Tomsk, Russian Federation. Int J Tuberc Lung Dis. 2012 Jul;16(7):891-6. doi: 10.5588/ijtld.11.0795. Epub 2012 Apr 9. (Full text)

  17. Keshavjee S, Gelmanova IY, Shin SS, Mishustin SP, Andreev YG, Atwood S, Furin JJ, Miller A. Hepatotoxicity during treatment for multidrug-resistant tuberculosis: occurrence, management and outcome. Int J Tuberc Lung Dis. 2012 May;16(5):596-603. doi: 10.5588/ijtld.11.0591. Epub 2012 Mar 7. (Full text)

  18. Gelmanova IY, Taran DV, Mishustin SP, Golubkov AA, Solovyova AV, Keshavjee S. 'Sputnik': a programmatic approach to improve tuberculosis treatment adherence and outcome among defaulters. International Journal of Tuberculosis and Lung Disease 2011;15:1373-9. (Full text)
     

 

© World Health Organization 2013

All rights reserved. No part of the contents of this CD-ROM may be reproduced, changed, adapted, translated, stored in a retrieval system or transmitted in any form or by any means without prior permission of the copyright holder, except to make a security backup. Requests for permissions, with a statement of the purpose and extent, should be addressed to WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (fax: +41 22 791 4806; e-mail: permissions@who.int)

The designations employed and the presentation of the material on this CD-ROM do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers and boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned

The World Health Organization does not warrant that the information contained on the CD-ROM is complete and correct. The Organization shall not be liable for any damages incurred as a result of use of the data or programs.

The procedures and programs used for access to or display of the data contained on the CD-ROM may not be reproduced, changed, adapted, translated, stored in a retrieval system (except for backup copies) or transmitted in any form or by any means without the prior permission of the copyright holder.

 

 

Created by WHO-Graphics